Furthermore, it is noteworthy that reduced SERCA-2 expression is considered to be a molecular marker of damage to cardiac performance during the development of left ventricular hypertrophy during heart failure [47]. This evidence concerns the gene ATP2A2 and left ventricular hypertrophy.